Physician profile
Gregory P Mindock
NPI 1790747665
$1,958.77
in general payments reported to CMS, 2019-2025
19 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $247 · 2022: $125 · 2023: $618 · 2024: $841 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,587.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $420.41 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $250.31 | 2023-2024 | Jardiance, Ofev |
| Abbvie INC. | $180.07 | 2023-2024 | |
| Amgen INC. | $177.67 | 2024 | Tepezza, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $170.07 | 2024 | Breztri, Airsupra, Farxiga |
| Abbott Laboratories | $153.89 | 2024 | Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $115.41 | 2021 | |
| Pfizer INC. | $111.75 | 2023-2024 | |
| Eisai INC. | $100.30 | 2025 | |
| Merck Sharp & Dohme LLC | $67.85 | 2023-2024 | Gardasil 9, Proquad, Vaxelis |
| Astellas Pharma US INC | $40.77 | 2023-2024 | Veozah |
| Lilly USA, LLC | $32.89 | 2023 | Emgality, Jardiance |
| Axsome Therapeutics, INC. | $27.18 | 2025 | Auvelity |
| Hologic Sales and Service, LLC | $24.81 | 2024 | Aptima |
| Mylan Specialty L.P. | $21.83 | 2024 | Yupelri |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $18.69 | 2024 | |
| Horizon Therapeutics Plc | $16.94 | 2023 | Krystexxa |
| Glaxosmithkline, LLC. | $14.16 | 2023 | Shingrix, Trelegy Ellipta, Arexvy |
| Exact Sciences Corporation | $13.77 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Mindock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.